Yahoo
HKSE - Delayed Quote HKD

Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

0.143 -0.010 (-6.54%)
At close: October 30 at 2:59:35 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
592,594.359
522,966.651
385,482.322
397,998.097
403,728.831
Cost of Revenue
537,377.792
487,292.067
365,259.446
376,632.434
388,906.493
Gross Profit
55,216.567
35,674.584
20,222.876
21,365.663
14,822.338
Operating Expense
25,232.780
29,363.155
35,362.029
31,200.528
34,034.608
Operating Income
29,983.787
6,311.429
-15,139.153
-9,834.865
-19,212.270
Net Non Operating Interest Income Expense
-3,271.255
-3,711.373
-4,533.027
-4,922.942
-5,638.553
Pretax Income
-89,183.467
-112,935.636
-38,206.601
-12,012.425
-24,055.155
Tax Provision
1,049.421
609.096
-221.318
-1,043.900
-507.104
Net Income Common Stockholders
-74,185.846
-90,820.485
-27,802.241
-20,159.658
-27,451.531
Diluted NI Available to Com Stockholders
-74,185.846
-90,820.485
-27,802.241
-20,159.658
-27,451.531
Basic EPS
-0.04
-0.04
-0.01
-0.01
-0.01
Diluted EPS
-0.04
-0.04
-0.01
-0.01
-0.01
Basic Average Shares
1,174,094.638
2,079,643.561
1,894,500
1,894,500
1,894,500
Diluted Average Shares
2,133,900
2,079,643.561
1,894,500
1,894,500
1,894,500
Rent Expense Supplemental
--
1,282.577
313.488
1,211.326
1,080.256
Total Expenses
562,610.572
516,655.222
400,621.475
407,832.962
422,941.101
Net Income from Continuing & Discontinued Operation
-74,185.846
-90,820.485
-27,802.241
-20,159.658
-27,451.531
Normalized Income
12,148.780
-4,485.860
-11,213.504
-17,353.236
-25,703.975
Interest Income
--
77.598
47.973
249.972
762.802
Interest Expense
3,348.853
3,788.971
4,581
5,172.914
6,401.355
Net Interest Income
-3,271.255
-3,711.373
-4,533.027
-4,922.942
-5,638.553
EBIT
-85,834.614
-109,146.665
-33,625.601
-6,839.511
-17,653.800
EBITDA
-85,834.614
-99,654.407
-24,498.078
4,794.098
-2,264.107
Reconciled Cost of Revenue
537,377.792
487,292.067
365,259.446
376,632.434
388,906.493
Reconciled Depreciation
--
9,492.258
9,127.523
11,633.609
15,389.693
Net Income from Continuing Operation Net Minority Interest
-74,185.846
-90,820.485
-29,647.974
-14,557.904
-25,008.297
Total Unusual Items Excluding Goodwill
-115,112.834
-115,112.834
-18,541.877
3,061.370
710.659
Total Unusual Items
-115,112.834
-115,112.834
-18,541.877
3,061.370
710.659
Normalized EBITDA
29,278.220
15,458.427
-5,956.201
1,732.728
-2,974.766
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-28,778.209
-28,778.209
-107.407
266.038
14.981
12/31/2022 - 6/18/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: